Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.050
-0.160 (-7.24%)
At close: Jun 5, 2026, 4:00 PM EDT
2.180
+0.130 (6.34%)
After-hours: Jun 5, 2026, 7:59 PM EDT
Lipocine Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Lipocine stock have an average target of $6.00, which predicts a 192.68% increase from the current stock price of 2.05.
Price Target: $6.00 (+192.68%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Lipocine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 1 | 1 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $6 | Buy | Maintains | $6 | +192.68% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Apr 6, 2026 |
Financial Forecast
Revenue This Year
776.40K
from 1.98M
Decreased by -60.72%
Revenue Next Year
1.09M
from 776.40K
Increased by 40.39%
EPS This Year
9.01
EPS Next Year
10.03
from 9.01
Increased by 11.32%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 776,400 | ||
| Avg | 776,400 | ||
| Low | 776,400 |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -60.7% | ||
| Avg | -60.7% | ||
| Low | -60.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 9.01 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | 11.3% | |
| Low | - |